Provider review
PrescrYbe review
By The Dose Brief Desk · Updated
PrescrYbe offers oral and injectable GLP-1 pathways, but no-autobilling language and subscription wording should be clarified together.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- Current exact product/term quote needs confirmation
- Tirzepatide
- Current exact product/term quote needs confirmation
- Availability
- Advertises all 50 states and DC, subject to medication and clinician eligibility.
- Treatment formats
- Semaglutide and tirzepatide; oral and injectable options.
Site describes no automatic billing in one place and subscriptions elsewhere; request the operative order terms.
A choice of routes
PrescrYbe’s GLP-1 page presents semaglutide and tirzepatide with oral and injectable options. The formulation is central to the comparison: a compounded oral product is not interchangeable with an approved oral brand or an injection merely because the ingredient name is familiar.
Ask for one unambiguous price
Several starting amounts appear on the page, but the reviewed evidence did not establish a dependable mapping of each amount to a product, dose and term. Request a quote that names all three, plus the total charge and included clinical services.
Resolve how reorders are charged
The page uses no-autobilling and no-recurring-membership language, while other answers refer to subscriptions. Ask whether each refill requires a new authorization, when payment is taken and what cancellation does to an order already approved by a clinician. Written order terms should settle the distinction.
Clinical and geographic arrangements
PrescrYbe identifies OpenLoop in its clinical arrangements and advertises availability across all states and DC. That still requires eligibility for your actual prescription and location. Obtain the assigned pharmacy and the contact route for clinical questions before deciding that the service meets your needs.
What stands out
- Oral and injection choices are visible
- Identifies a clinical services organization
What to check
- Billing language needs reconciliation
- No reliable single price fits all displayed options
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.